logo

Ligand Pharmaceuticals Inc (LGND)



Trade LGND now with
  Date
  Headline
1/16/2019 4:35:59 PM Rev. Fr. Emmanuel Lemelson Renews Calls For An Investigation In Ligand
12/18/2018 5:14:54 PM Ligand Pharmaceuticals Inc (LGND) Has Raised Its 2018 Revenue Estimate To $244 Mln From $240 Mln
12/18/2018 5:05:28 PM Ligand Pharmaceuticals Raises FY18 Outook; Now Expects Revenues Of Approx. $244 Mln And Adj. EPS Of Approx. $6.63
12/17/2018 4:02:21 PM Ligand Acquires Milestone And Royalty Rights To PTX-022 From Palvella Therapeutics
12/10/2018 10:03:02 AM Sermonix Announces FDA Acceptance Of IND Application On Phase 2 Trial Of Lasofoxifene
11/21/2018 9:01:12 AM Ligand Enters Worldwide OmniAb Partnership With IMetabolic Biopharma
11/8/2018 8:02:11 AM Ligand Pharma Q3 GAAP Net Income $67.4 Mln Or $2.80/shr Vs $8.4 Mln Or $0.36/Shr Last Year
10/10/2018 9:02:52 AM Ligand Pharma Closes Acquisition Of Vernalis
10/9/2018 12:05:15 PM Orchestra BioMed Adds Eric Rose, Jason Aryeh And Gary Pruden To Strategic Advisory Board
8/9/2018 8:12:10 AM Ligand Pharma Makes Offer To Acquire Vernalis For About $43 Mln In Cash
8/6/2018 4:02:52 PM Ligand Pharma Q2 EPS $2.99 Vs. $0.26 Year Ago
  
 
>